23andMe

23andMe is a consumer genetics and biotechnology company that offers direct‑to‑consumer DNA testing kits. The kits allow individuals to provide a saliva sample, which is then analyzed to generate reports on ancestry composition, genetic traits, and certain health‑related information such as carrier status for inherited conditions and predispositions to specific diseases. The company markets its services primarily to individual consumers in the United States, but it also makes its tests available in Canada, Europe, and other regions where regulatory clearance permits. In addition to ancestry and health reports, 23andMe provides tools for users to explore genetic matches with relatives who have also opted into the database.

Since its launch, 23andMe has accumulated a large genetic database that includes genotype data from millions of participants, making it one of the largest repositories of consumer‑generated genetic information worldwide. The company’s testing service has been used by people seeking insights into their family origins, health risks, and traits, contributing to research collaborations with academic and pharmaceutical partners. While exact user numbers are not disclosed in the prompt, public filings have indicated that the genotype database exceeds ten million individuals. This scale enables 23andMe to offer features such as DNA‑relative finding and to contribute to genome‑wide association studies.

23andMe distinguishes itself by being one of the few direct‑to‑consumer genetics firms to have received authorization from the U.S. Food and Drug Administration for certain health‑related reports, including those for BRCA1/BRCA2 and pharmacogenomic traits. The company also emphasizes a research‑driven model, allowing customers to consent to the use of their de‑identified data for scientific studies aimed at discovering genetic associations with diseases. Structurally, 23andMe operates as an independent, publicly traded corporation listed on the NASDAQ under the ticker ME, following its 2021 merger with a special purpose acquisition company. The firm’s headquarters are located in the United States of America, as noted in the provided context.